Author(s): Koob GF, Volkow ND
Drug addiction is a chronically relapsing disorder that has been characterized by (1) compulsion to seek and take the drug, (2) loss of control in limiting intake, and (3) emergence of a negative emotional state (eg, dysphoria, anxiety, irritability) reflecting a motivational withdrawal syndrome when access to the drug is prevented. Drug addiction has been conceptualized as a disorder that involves elements of both impulsivity and compulsivity that yield a composite addiction cycle composed of three stages: 'binge/intoxication', 'withdrawal/negative affect', and 'preoccupation/anticipation' (craving). Animal and human imaging studies have revealed discrete circuits that mediate the three stages of the addiction cycle with key elements of the ventral tegmental area and ventral striatum as a focal point for the binge/intoxication stage, a key role for the extended amygdala in the withdrawal/negative affect stage, and a key role in the preoccupation/anticipation stage for a widely distributed network involving the orbitofrontal cortex-dorsal striatum, prefrontal cortex, basolateral amygdala, hippocampus, and insula involved in craving and the cingulate gyrus, dorsolateral prefrontal, and inferior frontal cortices in disrupted inhibitory control. The transition to addiction involves neuroplasticity in all of these structures that may begin with changes in the mesolimbic dopamine system and a cascade of neuroadaptations from the ventral striatum to dorsal striatum and orbitofrontal cortex and eventually dysregulation of the prefrontal cortex, cingulate gyrus, and extended amygdala. The delineation of the neurocircuitry of the evolving stages of the addiction syndrome forms a heuristic basis for the search for the molecular, genetic, and neuropharmacological neuroadaptations that are key to vulnerability for developing and maintaining addiction.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/19710631
Author(s): Nutt DJ, King LA, Phillips LD
Author(s): Garbutt JC
Author(s): Caputo F, Vignoli T, Grignaschi A, Cibin M, Addolorato G, et al.
Author(s): NHS Evidence provided by NICE clinical guideline
Author(s): Zindel LR, Kranzler HR
Author(s): Leone MA, Vigna-Taglianti F, Avanzi G, Brambilla R, Faggiano
Author(s): Enoch MA
Author(s): Hofmann W, Friese M, Strack F
Author(s): Karoly HC, YorkWilliams SL, Hutchison KE
Author(s): Gilpin NW, Koob GF
Author(s): Herz A
Author(s): Fields HL, Margolis EB
Author(s): Gonzales RA, Weiss F
Author(s): Koob GF
Author(s): Dahchour A, De Witte P, Bolo N, NÃ©dÃ©lec JF, Muzet M, et al.
Author(s): Volkow ND, Fowler JS, Wang GJ
Author(s): Kamarajan C, Porjesz B, Jones KA, Choi K, Chorlian DB, et al.
Author(s): Perry VH, Nicoll JA, Holmes C
Author(s): Goldstein RZ, Volkow ND
Author(s): Woody GE
Author(s): Besson J, Aeby F, Kasas A, Lehert P, Potgieter A
Author(s): Lee MR, Leggio L